260 related articles for article (PubMed ID: 2016542)
1. Characterization of an immunoreactive 93-kDa core protein of Borrelia burgdorferi with a human IgG monoclonal antibody.
Volkman DJ; Luft BJ; Gorevic PD; Schultz J; Padovano L
J Immunol; 1991 May; 146(9):3177-82. PubMed ID: 2016542
[TBL] [Abstract][Full Text] [Related]
2. Cross-antigenicity between the major surface proteins (ospA and ospB) and other proteins of Borrelia burgdorferi.
Jiang W; Luft BJ; Munoz P; Dattwyler RJ; Gorevic PD
J Immunol; 1990 Jan; 144(1):284-9. PubMed ID: 2295795
[TBL] [Abstract][Full Text] [Related]
3. Experimental Borrelia burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with resistance and susceptibility to development of arthritis.
Schaible UE; Kramer MD; Wallich R; Tran T; Simon MM
Eur J Immunol; 1991 Oct; 21(10):2397-405. PubMed ID: 1915553
[TBL] [Abstract][Full Text] [Related]
4. Epitopes on the outer surface protein A of Borrelia burgdorferi recognized by antibodies and T cells of patients with Lyme disease.
Shanafelt MC; Anzola J; Soderberg C; Yssel H; Turck CW; Peltz G
J Immunol; 1992 Jan; 148(1):218-24. PubMed ID: 1370170
[TBL] [Abstract][Full Text] [Related]
5. Molecular mimicry and Lyme borreliosis: a shared antigenic determinant between Borrelia burgdorferi and human tissue.
Aberer E; Brunner C; Suchanek G; Klade H; Barbour A; Stanek G; Lassmann H
Ann Neurol; 1989 Dec; 26(6):732-7. PubMed ID: 2481425
[TBL] [Abstract][Full Text] [Related]
6. Immunologic and structural characterization of the dominant 66- to 73-kDa antigens of Borrelia burgdorferi.
Luft BJ; Gorevic PD; Jiang W; Munoz P; Dattwyler RJ
J Immunol; 1991 Apr; 146(8):2776-82. PubMed ID: 2016526
[TBL] [Abstract][Full Text] [Related]
7. Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease.
Sears JE; Fikrig E; Nakagawa TY; Deponte K; Marcantonio N; Kantor FS; Flavell RA
J Immunol; 1991 Sep; 147(6):1995-2000. PubMed ID: 1716290
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to borrelial VlsE IR6 peptide variants.
Sillanpää H; Lahdenne P; Sarvas H; Arnez M; Steere A; Peltomaa M; Seppälä I
Int J Med Microbiol; 2007 Feb; 297(1):45-52. PubMed ID: 17234451
[TBL] [Abstract][Full Text] [Related]
9. Immune recognition of human Hsp60 by Lyme disease patient sera.
Girouard L; Laux DC; Jindal S; Nelson DR
Microb Pathog; 1993 Apr; 14(4):287-97. PubMed ID: 8100982
[TBL] [Abstract][Full Text] [Related]
10. Frequency and specificity of antibodies that crossreact with Borrelia burgdorferi antigens.
Fawcett PT; Gibney KM; Rose CD; Dubbs SB; Doughty RA
J Rheumatol; 1992 Apr; 19(4):582-7. PubMed ID: 1593581
[TBL] [Abstract][Full Text] [Related]
11. Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.
Kalish RA; McHugh G; Granquist J; Shea B; Ruthazer R; Steere AC
Clin Infect Dis; 2001 Sep; 33(6):780-5. PubMed ID: 11512082
[TBL] [Abstract][Full Text] [Related]
12. Serum antibodies against particular antigens of Borrelia burgdorferi sensu stricto and their potential in the diagnosis of canine Lyme borreliosis.
Wieler LH; Szattelberger C; Weiss R; Bauerfeind R; Kutzer P; Failing K; Baljer G
Berl Munch Tierarztl Wochenschr; 1999 Dec; 112(12):465-71. PubMed ID: 10638032
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing the antigenic reactivity of Borrelia burgdorferi, the Lyme disease spirochete.
Schwan TG; Simpson WJ
Scand J Infect Dis Suppl; 1991; 77():94-101. PubMed ID: 1947819
[TBL] [Abstract][Full Text] [Related]
14. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
Lebech AM
APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
[TBL] [Abstract][Full Text] [Related]
15. [Immunochemical analysis of the immune response in late manifestations of Lyme borreliosis].
Wilske B; Preac-Mursic V; Schierz G; Gueye W; Herzer P; Weber K
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 267(4):549-58. PubMed ID: 3381603
[TBL] [Abstract][Full Text] [Related]
16. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
Buechner SA; Lautenschlager S; Itin P; Bircher A; Erb P
Arch Dermatol; 1995 Jun; 131(6):673-7. PubMed ID: 7778918
[TBL] [Abstract][Full Text] [Related]
17. Development and laboratory evaluation of a new recombinant ELISA for the serodiagnosis of Lyme disease.
Hunfeld KP; Ernst M; Zachary P; Jaulhac B; Sonneborn HH; Brade V
Wien Klin Wochenschr; 2002 Jul; 114(13-14):580-5. PubMed ID: 12422605
[TBL] [Abstract][Full Text] [Related]
18. Serodiagnosis of Lyme borreliosis using detection of different immunoglobulin (sub)classes by enzyme-linked immunosorbent assay and Western blotting.
Goossens HA; van den Bogaard AE; Nohlmans MK
Clin Lab; 2001; 47(1-2):41-9. PubMed ID: 11214222
[TBL] [Abstract][Full Text] [Related]
19. [Diagnosis of Lyme borreliosis with western blotting].
Hulínská D
Epidemiol Mikrobiol Imunol; 1997 Mar; 46(1):3-8. PubMed ID: 9162453
[TBL] [Abstract][Full Text] [Related]
20. Isolation of Borrelia burgdorferi from a Lyme seronegative patient in northern Italy: expression of OspB immunodominant proteins on the isolated strain.
Cinco M; Trevisan G; Agolzer A
Microbiologica; 1992 Apr; 15(2):95-8. PubMed ID: 1602993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
